We both lost our jobs as public health diplomats with the U.S. Agency for International Development last summer. Our termination from federal service also meant that both of us lo ...
WuXi AppTec, the Chinese pharma giant with extensive ties with U.S. companies, appears to be thriving now that the threat of ...
ROAI isn't about flashy demos or model size. It's about measurable improvements,” writes Sanofi CEO Paul Hudson.
During a two-hour experimental chat with a therapist chatbot character, it “actively encouraged me to disregard my ...
Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.
The deals keeps coming. Merck this morning said it will acquire Cidara Therapeutics, the maker of an experimental flu therapy ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...
Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...
Jenna Norton, a vocal critic of Trump administration actions at the NIH, was abruptly placed on administrative leave this ...
Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the ...
Weight loss drugs have skyrocketed in prevalence in recent years, according to a new KFF poll on GLP-1 drugs and drug prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback